SG Americas Securities’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.87M | Buy |
38,482
+9,141
| +31% | +$445K | 0.01% | 724 |
|
2025
Q1 | $998K | Buy |
29,341
+8,240
| +39% | +$280K | ﹤0.01% | 1050 |
|
2024
Q4 | $831K | Sell |
21,101
-4,610
| -18% | -$182K | ﹤0.01% | 824 |
|
2024
Q3 | $1.21M | Sell |
25,711
-468
| -2% | -$22K | ﹤0.01% | 811 |
|
2024
Q2 | $1.41M | Sell |
26,179
-12,627
| -33% | -$682K | 0.01% | 1042 |
|
2024
Q1 | $2.65M | Sell |
38,806
-9,207
| -19% | -$628K | 0.01% | 722 |
|
2023
Q4 | $3.01M | Buy |
48,013
+24,850
| +107% | +$1.56M | 0.03% | 445 |
|
2023
Q3 | $1.05M | Sell |
23,163
-3,818
| -14% | -$173K | 0.01% | 1133 |
|
2023
Q2 | $1.52M | Buy |
26,981
+521
| +2% | +$29.3K | 0.01% | 786 |
|
2023
Q1 | $1.2M | Sell |
26,460
-873
| -3% | -$39.5K | 0.01% | 927 |
|
2022
Q4 | $1.11M | Buy |
27,333
+14,493
| +113% | +$589K | 0.01% | 781 |
|
2022
Q3 | $839K | Sell |
12,840
-50,372
| -80% | -$3.29M | 0.01% | 979 |
|
2022
Q2 | $3.84M | Buy |
63,212
+58,765
| +1,321% | +$3.57M | 0.04% | 326 |
|
2022
Q1 | $279K | Sell |
4,447
-18,703
| -81% | -$1.17M | ﹤0.01% | 1994 |
|
2021
Q4 | $1.75M | Sell |
23,150
-48,806
| -68% | -$3.7M | 0.01% | 1090 |
|
2021
Q3 | $8.05M | Buy |
71,956
+11,234
| +19% | +$1.26M | 0.04% | 291 |
|
2021
Q2 | $9.83M | Buy |
60,722
+1,012
| +2% | +$164K | 0.05% | 319 |
|
2021
Q1 | $7.28M | Buy |
59,710
+54,346
| +1,013% | +$6.62M | 0.04% | 333 |
|
2020
Q4 | $821K | Sell |
5,364
-1,543
| -22% | -$236K | ﹤0.01% | 1446 |
|
2020
Q3 | $578K | Sell |
6,907
-1,464
| -17% | -$123K | ﹤0.01% | 1280 |
|
2020
Q2 | $615K | Buy |
+8,371
| New | +$615K | 0.01% | 1609 |
|
2020
Q1 | – | Sell |
-6,585
| Closed | -$401K | – | 2877 |
|
2019
Q4 | $401K | Sell |
6,585
-11,919
| -64% | -$726K | ﹤0.01% | 1685 |
|
2019
Q3 | $758K | Buy |
+18,504
| New | +$758K | 0.01% | 1388 |
|